Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.51B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$411M |
| 3 |
Microsoft
MSFT
|
+$300M |
| 4 |
Apple
AAPL
|
+$284M |
| 5 |
Visa
V
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apollo Global Management
APO
|
+$254M |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$178M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$177M |
| 4 |
Blackstone
BX
|
+$139M |
| 5 |
Exelon
EXC
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.38% |
| 2 | Technology | 11.34% |
| 3 | Miscellaneous | 10.58% |
| 4 | Energy | 8.74% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2551
Franklin Electric
FELE
$4.36B
| $614K | ﹤0.01% |
10,718
+1,419
| +15% | +$75K |
2013 Q2
26 quarters
|
|
2552
Healthcare Services Group
HCSG
$1.43B
| $613K | ﹤0.01% |
25,218
-179,031
| -88% | -$4.44M |
2013 Q2
26 quarters
|
|
2553
Logitech
LOGI
$14.9B
| $613K | ﹤0.01% |
12,993
+343
| +3% | +$14.6K |
2014 Q1
23 quarters
|
|
|
LN
2554
DELISTED
LINE Corporation
LN
| $613K | ﹤0.01% |
12,501
+12
| +0.1% | +$513 |
2017 Q1
11 quarters
|
|
2555
Pinnacle Financial Partners Inc
PNFP
$14.5B
| $612K | ﹤0.01% |
9,569
+5,552
| +138% | +$335K |
2013 Q2
26 quarters
|
|
2556
CALL
QuinStreet
QNST
$857M
| $612K | ﹤0.01% |
40,000
-75,000
| -65% | -$1.07M |
2019 Q3
1 quarter
|
|
2557
BlackLine
BL
$1.59B
| $610K | ﹤0.01% |
11,843
+1,739
| +17% | +$86.8K |
2018 Q1
7 quarters
|
|
2558
PLDT
PHI
$3.79B
| $610K | ﹤0.01% |
30,555
-58
| -0.2% | -$1.21K |
2013 Q2
26 quarters
|
|
|
FTR
2559
DELISTED
Frontier Communications Corp.
FTR
| $610K | ﹤0.01% |
686,867
+59,089
| +9% | +$48.2K |
2013 Q2
26 quarters
|
|
2560
Arcturus Therapeutics
ARCT
$370M
| $608K | ﹤0.01% |
+55,926
| New | +$585K |
2019 Q4
0 quarters
|
|
2561
Natural Resource Partners
NRP
$1.45B
| $607K | ﹤0.01% |
30,150
+134
| +0.4% | +$3.1K |
2019 Q1
3 quarters
|
|
|
PCTI
2562
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $604K | ﹤0.01% |
+71,294
| New | +$592K |
2019 Q4
0 quarters
|
|
|
RETA
2563
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $604K | ﹤0.01% |
2,957
+1,123
| +61% | +$205K |
2018 Q2
6 quarters
|
|
|
LOGM
2564
DELISTED
LogMein, Inc.
LOGM
| $604K | ﹤0.01% |
7,040
+4,044
| +135% | +$300K |
2013 Q2
26 quarters
|
|
2565
Calumet Specialty Products
CLMT
$4.86B
| $602K | ﹤0.01% |
+165,000
| New | +$570K |
2019 Q4
0 quarters
|
|
2566
Cinemark Holdings
CNK
$4.18B
| $600K | ﹤0.01% |
17,735
+8,865
| +100% | +$314K |
2013 Q2
26 quarters
|
|
2567
CALL
National CineMedia
NCMI
$198M
| $600K | ﹤0.01% |
+8,230
| New | +$620K |
2019 Q4
0 quarters
|
|
2568
PUT
Under Armour
UAA
$2.02B
| $598K | ﹤0.01% |
27,700
+27,400
| +9,133% | +$532K |
2016 Q4
12 quarters
|
|
|
FTR
2569
PUT
DELISTED
Frontier Communications Corp.
FTR
| $597K | ﹤0.01% |
671,300
+55,300
| +9% | +$45.1K |
2019 Q1
3 quarters
|
|
2570
Moderna
MRNA
$75.9B
| $591K | ﹤0.01% |
30,165
+528
| +2% | +$9.37K |
2019 Q1
3 quarters
|
|
2571
BJ's Restaurants
BJRI
$1.32B
| $589K | ﹤0.01% |
15,516
+12,838
| +479% | +$492K |
2013 Q2
26 quarters
|
|
|
CPRX
2572
DELISTED
Catalyst Pharmaceutical
CPRX
| $588K | ﹤0.01% |
156,897
+143,434
| +1,065% | +$671K |
2018 Q1
7 quarters
|
|
2573
US Physical Therapy
USPH
$1.25B
| $588K | ﹤0.01% |
5,148
+240
| +5% | +$29.9K |
2013 Q2
26 quarters
|
|
|
XONE
2574
DELISTED
The ExOne Company
XONE
| $587K | ﹤0.01% |
78,700
+4,900
| +7% | +$34.9K |
2019 Q3
1 quarter
|
|
|
XONE
2575
PUT
DELISTED
The ExOne Company
XONE
| $587K | ﹤0.01% |
78,700
+4,900
| +7% | +$34.9K |
2019 Q3
1 quarter
|
|
Similar funds
Bank of Montreal's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of Montreal held 5,174 positions worth $133B, up 15% from $116B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of Montreal deployed $8.58B of net new capital in Q4 2019, opening 425 new positions and adding to 2,835 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 1,035,443 shares worth $86.2M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 28% a quarter earlier, followed by Technology and Miscellaneous.
On the sell side, the largest reduction was Apollo Global Management, an estimated $254M trimmed.
- Bank of Montreal's largest Q4 2019 buy was Vanguard Long-Term Treasury ETF: 1,035,443 shares worth $86.2M.
- Bank of Montreal added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.51B increase.
- Bank of Montreal's biggest Q4 2019 reduction was Apollo Global Management, cutting an estimated $254M.
- Bank of Montreal fully exited Buckeye Partners, L.P. in Q4 2019, selling an estimated $125M.
- Bank of Montreal's ten largest holdings make up 20% of its $133B portfolio in Q4 2019.
- Bank of Montreal opened 425 new positions and closed 298 in Q4 2019.
- Bank of Montreal's portfolio value rose 15% quarter-over-quarter to $133B.
Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.